InspireMD to price $40 million public sale of stock with 15% greenshoe

Proceeds fund MGuard, redemption of company's convertible debentures

By Devika Patel

Knoxville, Tenn., Sept. 25 - InspireMD, Inc. said it plans to price a $40 million public sale of its common stock with a 30-day, 15% greenshoe.

Cowen and Co., LLC is sole bookrunner, and JMP Securities is the co-lead manager.

Proceeds will be used to support the commercialization of MGuard, to redeem the company's convertible debentures and for general corporate purposes.

InspireMD is a Tel Aviv medical device company developing its proprietary stent system technology, MGuard.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.